Estalis Sequi

Country: New Zealand

Language: English

Source: Medsafe (Medicines Safety Authority)

Active ingredient:

Estradiol hemihydrate 0.78mg equivalent to 50 µg/24 hours;  ; Estradiol hemihydrate 0.62mg equivalent to 50 µg/24 hours; Norethisterone acetate 2.7mg equivalent to 140 µg/24 hours;  

Available from:

Novartis New Zealand Ltd

INN (International Name):

Estradiol hemihydrate 0.78 mg (=50 µg/24 hours)

Dosage:

50/140

Pharmaceutical form:

Transdermal patch

Composition:

Active: Estradiol hemihydrate 0.78mg equivalent to 50 µg/24 hours   Excipient: Acrylic adhesive Dipropylene glycol Oleic acid Povidone Silicone adhesive Active: Estradiol hemihydrate 0.62mg equivalent to 50 µg/24 hours Norethisterone acetate 2.7mg equivalent to 140 µg/24 hours   Excipient: Acrylic adhesive Dipropylene glycol Oleic acid Povidone Silicone adhesive

Units in package:

Combination pack, Paper/PE/Al/PE composite pouches - 8 per carton, 8 patches

Class:

Prescription

Prescription type:

Prescription

Manufactured by:

NV Organon

Product summary:

Package - Contents - Shelf Life: Combination pack, Paper/PE/Al/PE composite pouches - 8 per carton - 8 patches - 24 months from date of manufacture stored 18 months at 2-8°C, with additional 6 months allowed below 25°C

Authorization date:

2006-02-22